drug · oligonucleotide
patient view →plozasiran sodium
Marketedupdated 2mo agoby $ARWR ARROWHEAD PHARMACEUTICALS, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Oligonucleotide drug with a maximum clinical stage of Unknown (across all indications), with 3 investigational indications.
all catalysts(1)
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that